Millipore Sigma Vibrant Logo

204910 Complement C9, Human

Complement C9, Human, CAS 80295-59-6, is a native, single-chain glycoprotein present in normal human serum at 60 µg/ml.

Complement C9, Human: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
View Products on Sigmaaldrich.com
204910
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
204910-250UG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 250 μg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewNative, human C9 complement component. Single-chain glycoprotein present in normal human serum at 60 µg/ml. On activation of complement via either the classical or alternative pathway, formation of the C5b fragment initiates assembly of the C5b-9 complement membrane attack complex (MAC) on target surfaces. Full lytic activity of MAC occurs only after binding of three to six C9 molecules to each C5b-8 complex.
      Catalogue Number204910
      Brand Family Calbiochem®
      References
      ReferencesStanley, K.K., et al. 1985. EMBO J. 4, 375.
      Biesecker, G. and Muller-Eberhard, H.J. 1980. J. Immunol. 124, 1291.
      Product Information
      CAS number80295-59-6
      FormLiquid
      FormulationIn PBS, pH 7.2, filtered through a 0.22 µm pore size filter.
      Quality LevelMQ200
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Specific Activity≥150,000 C9H50 units/mg
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      ContaminantsIgG, IgA, IgM, albumin, C3, C4, C5, C6, C7, or C8: ≤trace amounts
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      204910-250UG 04055977219890

      Documentation

      Complement C9, Human MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Complement C9, Human Certificati d'Analisi

      TitoloNumero di lotto
      204910

      Riferimenti bibliografici

      Panoramica delle referenze
      Stanley, K.K., et al. 1985. EMBO J. 4, 375.
      Biesecker, G. and Muller-Eberhard, H.J. 1980. J. Immunol. 124, 1291.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-May-2008 RFH
      DescriptionNative, human C9 complement component. Single-chain glycoprotein present in normal human serum at 60 µg/ml. On activation of complement via either the classical or alternative pathway, formation of the C5b fragment initiates assembly of C5b-9 complement membrane attack complex (MAC) on target surfaces. Full lytic activity of MAC occurs only after binding of three to six C9 molecules to each C5b-8 complex.
      FormLiquid
      FormulationIn PBS, pH 7.2, filtered through a 0.22 µm pore size filter.
      Concentration Label Please refer to vial label for lot-specific concentration
      SourcePrepared from serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      CAS number80295-59-6
      Purity≥95% by SDS-PAGE
      ContaminantsIgG, IgA, IgM, albumin, C3, C4, C5, C6, C7, or C8: ≤trace amounts
      Specific activity≥150,000 C9H50 units/mg
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesStanley, K.K., et al. 1985. EMBO J. 4, 375.
      Biesecker, G. and Muller-Eberhard, H.J. 1980. J. Immunol. 124, 1291.